Get started
Author

Alex Clavería-Cabello

Observed names: Alex Claveria, Alex Claveria-Cabello, Claveria-Cabello, A. (Alex)
ORCID: 0000-0002-4849-1764
Observed ORCID: 0000-0002-4849-1764
OpenAlex ID: A5036616859
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
2020 · Marina Barcena-Varela, Hannah Paish, et al. · Gut · 104
PDF
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
2023 · Alex Clavería-Cabello, Jose Maria Herranz, et al. · Journal of Hepatology · 61
PDF
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
2020 · Alex Claveria-Cabello, Leticia Colyn, et al. · Cells · 44
PDF
Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
2023 · Jose M. Herranz, Amaya López-Pascual, et al. · Journal of Physiology and Biochemistry · 22
PDF
Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis
2020 · Alex Claveria-Cabello, Leticia Colyn, et al. · Cancers · 15
HIF2α Activation in NASH: A New Force Pushing Toward HCC
2021 · Alex Clavería-Cabello, Matías A. Avila · Cellular and Molecular Gastroenterology and Hepatology · 3
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
2023 · Alex Claveria-Cabello, José María Herranz, et al. · Journal of Hepatology · 1
Epigenetics in hepatoblastoma
2021 · Alex Clavería-Cabello, María Arechederra, et al. · Hepatoma Research · 1
PDF
Epigenetic mechanisms in chronic liver disease and pediatric liver cancer
2023 · Claveria-Cabello, A. (Alex) · Deposito Adademico Digital Universidad De Navarra (University of Navarra)
The inhibition of the epigenetic efectors DNMT1 and G9a as a potential therapeutic strategy against the non-alcoholic fatty liver development
2022 · José María Herranz, Alex Claveria-Cabello, et al. · Journal of Hepatology
Dual inhibition of DNA methyltransferase 1 and the histone methyltransferase G9a as a new therapeutic strategy in hepatoblastoma
2020 · Maite G. Fernandez-Barrena, Alex Claveria-Cabello, et al. · Journal of Hepatology
PDF
Epigenetic mechanism and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNA methyltransferase 1 for the inhibition of liver fibrosis
2020 · Marina Bárcena-Varela, Hannah Paish, et al. · Journal of Hepatology
Works count: 13
Citation count: 251
H-index: 5
I10-index: 5
Year
Topic
Type